Announcements Trials
Browse Landscape

Status

Completed 8Unknown 6Active not recruiting 4Recruiting 3Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Head & Neck 1

Conditions

Recurrence 1Neoplasms 1Mouth Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × High-Throughput Nucleotide Sequencing × Clear all
NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

Recruiting
88 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05382585 2024-08-13

Newer Therapeutic Targets in Head and Neck Cancers

Banaras Hindu University

Recruiting
200 enrolled
Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡